Global Anthrax Vaccines Market Research Report 2024(Status and Outlook)

Global Anthrax Vaccines Market Research Report 2024(Status and Outlook)



Report Overview:

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.

The Global Anthrax Vaccines Market Size was estimated at USD 710.47 million in 2023 and is projected to reach USD 1102.61 million by 2029, exhibiting a CAGR of 7.60% during the forecast period.

This report provides a deep insight into the global Anthrax Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anthrax Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anthrax Vaccines market in any manner.

Global Anthrax Vaccines Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Emergent BioSolutions

Merial

Merck

Zoetis

Bayer Sanidad Animal

Colorado Serum

PharmAthene

Tiankang

Biogénesis-Bago

CAVAC

Rosenbusch

Agrovet

Vecol

CVCRI

IVPM

Prondil

CDV

Indian Immunologicals

Botswana Vaccine Institute

Ceva Santé Animale

Intervac

JOVAC

Market Segmentation (by Type)

Live Vaccines

Cell free PA Vaccines

Market Segmentation (by Application)

Human Use

Animal Use

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Anthrax Vaccines Market
  • Overview of the regional outlook of the Anthrax Vaccines Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anthrax Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anthrax Vaccines
1.2 Key Market Segments
1.2.1 Anthrax Vaccines Segment by Type
1.2.2 Anthrax Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anthrax Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Anthrax Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anthrax Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anthrax Vaccines Market Competitive Landscape
3.1 Global Anthrax Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anthrax Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anthrax Vaccines Sales Sites, Area Served, Product Type
3.6 Anthrax Vaccines Market Competitive Situation and Trends
3.6.1 Anthrax Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anthrax Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anthrax Vaccines Industry Chain Analysis
4.1 Anthrax Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anthrax Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anthrax Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anthrax Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Anthrax Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Anthrax Vaccines Price by Type (2019-2024)
7 Anthrax Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anthrax Vaccines Market Sales by Application (2019-2024)
7.3 Global Anthrax Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Anthrax Vaccines Sales Growth Rate by Application (2019-2024)
8 Anthrax Vaccines Market Segmentation by Region
8.1 Global Anthrax Vaccines Sales by Region
8.1.1 Global Anthrax Vaccines Sales by Region
8.1.2 Global Anthrax Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Anthrax Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anthrax Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anthrax Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anthrax Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anthrax Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Emergent BioSolutions
9.1.1 Emergent BioSolutions Anthrax Vaccines Basic Information
9.1.2 Emergent BioSolutions Anthrax Vaccines Product Overview
9.1.3 Emergent BioSolutions Anthrax Vaccines Product Market Performance
9.1.4 Emergent BioSolutions Business Overview
9.1.5 Emergent BioSolutions Anthrax Vaccines SWOT Analysis
9.1.6 Emergent BioSolutions Recent Developments
9.2 Merial
9.2.1 Merial Anthrax Vaccines Basic Information
9.2.2 Merial Anthrax Vaccines Product Overview
9.2.3 Merial Anthrax Vaccines Product Market Performance
9.2.4 Merial Business Overview
9.2.5 Merial Anthrax Vaccines SWOT Analysis
9.2.6 Merial Recent Developments
9.3 Merck
9.3.1 Merck Anthrax Vaccines Basic Information
9.3.2 Merck Anthrax Vaccines Product Overview
9.3.3 Merck Anthrax Vaccines Product Market Performance
9.3.4 Merck Anthrax Vaccines SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Zoetis
9.4.1 Zoetis Anthrax Vaccines Basic Information
9.4.2 Zoetis Anthrax Vaccines Product Overview
9.4.3 Zoetis Anthrax Vaccines Product Market Performance
9.4.4 Zoetis Business Overview
9.4.5 Zoetis Recent Developments
9.5 Bayer Sanidad Animal
9.5.1 Bayer Sanidad Animal Anthrax Vaccines Basic Information
9.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Overview
9.5.3 Bayer Sanidad Animal Anthrax Vaccines Product Market Performance
9.5.4 Bayer Sanidad Animal Business Overview
9.5.5 Bayer Sanidad Animal Recent Developments
9.6 Colorado Serum
9.6.1 Colorado Serum Anthrax Vaccines Basic Information
9.6.2 Colorado Serum Anthrax Vaccines Product Overview
9.6.3 Colorado Serum Anthrax Vaccines Product Market Performance
9.6.4 Colorado Serum Business Overview
9.6.5 Colorado Serum Recent Developments
9.7 PharmAthene
9.7.1 PharmAthene Anthrax Vaccines Basic Information
9.7.2 PharmAthene Anthrax Vaccines Product Overview
9.7.3 PharmAthene Anthrax Vaccines Product Market Performance
9.7.4 PharmAthene Business Overview
9.7.5 PharmAthene Recent Developments
9.8 Tiankang
9.8.1 Tiankang Anthrax Vaccines Basic Information
9.8.2 Tiankang Anthrax Vaccines Product Overview
9.8.3 Tiankang Anthrax Vaccines Product Market Performance
9.8.4 Tiankang Business Overview
9.8.5 Tiankang Recent Developments
9.9 Biogénesis-Bago
9.9.1 Biogénesis-Bago Anthrax Vaccines Basic Information
9.9.2 Biogénesis-Bago Anthrax Vaccines Product Overview
9.9.3 Biogénesis-Bago Anthrax Vaccines Product Market Performance
9.9.4 Biogénesis-Bago Business Overview
9.9.5 Biogénesis-Bago Recent Developments
9.10 CAVAC
9.10.1 CAVAC Anthrax Vaccines Basic Information
9.10.2 CAVAC Anthrax Vaccines Product Overview
9.10.3 CAVAC Anthrax Vaccines Product Market Performance
9.10.4 CAVAC Business Overview
9.10.5 CAVAC Recent Developments
9.11 Rosenbusch
9.11.1 Rosenbusch Anthrax Vaccines Basic Information
9.11.2 Rosenbusch Anthrax Vaccines Product Overview
9.11.3 Rosenbusch Anthrax Vaccines Product Market Performance
9.11.4 Rosenbusch Business Overview
9.11.5 Rosenbusch Recent Developments
9.12 Agrovet
9.12.1 Agrovet Anthrax Vaccines Basic Information
9.12.2 Agrovet Anthrax Vaccines Product Overview
9.12.3 Agrovet Anthrax Vaccines Product Market Performance
9.12.4 Agrovet Business Overview
9.12.5 Agrovet Recent Developments
9.13 Vecol
9.13.1 Vecol Anthrax Vaccines Basic Information
9.13.2 Vecol Anthrax Vaccines Product Overview
9.13.3 Vecol Anthrax Vaccines Product Market Performance
9.13.4 Vecol Business Overview
9.13.5 Vecol Recent Developments
9.14 CVCRI
9.14.1 CVCRI Anthrax Vaccines Basic Information
9.14.2 CVCRI Anthrax Vaccines Product Overview
9.14.3 CVCRI Anthrax Vaccines Product Market Performance
9.14.4 CVCRI Business Overview
9.14.5 CVCRI Recent Developments
9.15 IVPM
9.15.1 IVPM Anthrax Vaccines Basic Information
9.15.2 IVPM Anthrax Vaccines Product Overview
9.15.3 IVPM Anthrax Vaccines Product Market Performance
9.15.4 IVPM Business Overview
9.15.5 IVPM Recent Developments
9.16 Prondil
9.16.1 Prondil Anthrax Vaccines Basic Information
9.16.2 Prondil Anthrax Vaccines Product Overview
9.16.3 Prondil Anthrax Vaccines Product Market Performance
9.16.4 Prondil Business Overview
9.16.5 Prondil Recent Developments
9.17 CDV
9.17.1 CDV Anthrax Vaccines Basic Information
9.17.2 CDV Anthrax Vaccines Product Overview
9.17.3 CDV Anthrax Vaccines Product Market Performance
9.17.4 CDV Business Overview
9.17.5 CDV Recent Developments
9.18 Indian Immunologicals
9.18.1 Indian Immunologicals Anthrax Vaccines Basic Information
9.18.2 Indian Immunologicals Anthrax Vaccines Product Overview
9.18.3 Indian Immunologicals Anthrax Vaccines Product Market Performance
9.18.4 Indian Immunologicals Business Overview
9.18.5 Indian Immunologicals Recent Developments
9.19 Botswana Vaccine Institute
9.19.1 Botswana Vaccine Institute Anthrax Vaccines Basic Information
9.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Overview
9.19.3 Botswana Vaccine Institute Anthrax Vaccines Product Market Performance
9.19.4 Botswana Vaccine Institute Business Overview
9.19.5 Botswana Vaccine Institute Recent Developments
9.20 Ceva Santé Animale
9.20.1 Ceva Santé Animale Anthrax Vaccines Basic Information
9.20.2 Ceva Santé Animale Anthrax Vaccines Product Overview
9.20.3 Ceva Santé Animale Anthrax Vaccines Product Market Performance
9.20.4 Ceva Santé Animale Business Overview
9.20.5 Ceva Santé Animale Recent Developments
9.21 Intervac
9.21.1 Intervac Anthrax Vaccines Basic Information
9.21.2 Intervac Anthrax Vaccines Product Overview
9.21.3 Intervac Anthrax Vaccines Product Market Performance
9.21.4 Intervac Business Overview
9.21.5 Intervac Recent Developments
9.22 JOVAC
9.22.1 JOVAC Anthrax Vaccines Basic Information
9.22.2 JOVAC Anthrax Vaccines Product Overview
9.22.3 JOVAC Anthrax Vaccines Product Market Performance
9.22.4 JOVAC Business Overview
9.22.5 JOVAC Recent Developments
10 Anthrax Vaccines Market Forecast by Region
10.1 Global Anthrax Vaccines Market Size Forecast
10.2 Global Anthrax Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anthrax Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Anthrax Vaccines Market Size Forecast by Region
10.2.4 South America Anthrax Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anthrax Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anthrax Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anthrax Vaccines by Type (2025-2030)
11.1.2 Global Anthrax Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anthrax Vaccines by Type (2025-2030)
11.2 Global Anthrax Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Anthrax Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Anthrax Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings